2021 Revenues ($USD) : $4,269,300,000
2021 Revenues (foreign currencies) : € 3,745,000,000
2021 R&D spend : $221,160,000
2021 Number of Employees : 30,000
Fiscal Year End : 12/31/2020
Key People : Rice Powell, CEO and chair of the Management Board; Helen Giza, CFO; Franklin W. Maddux, global CMO; Dr. Katarzyna Mazur-Hofsäß, CEO for Europe, Middle East and Africa; Olaf Schermeier, CEO for global R&D; William Valle, CEO for North America; Kent Wanzek, CEO for global manufacturing, quality and supply; Harry de Wit, CEO for Asia-Pacific.

About the company: Fresenius Medical Care is one of the world’s top providers of products and services for people with renal diseases. Severe COVID-19 cases can cause acute kidney failure, so Fresenius Medical Care expanded production of acute dialysis products at short notice at the start of the pandemic. Around the same time, FDA cleared the company’s Novalung system — which reduces or eliminates the need for mechanical ventilation by pumping a person’s blood through an oxygenator for gas exchange. –CN